Replimune Group Files 8-K with Corporate Details
Ticker: REPL · Form: 8-K · Filed: 2024-06-03T00:00:00.000Z
Sentiment: neutral
Topics: corporate-filing, 8-K
TL;DR
Replimune Group filed an 8-K on June 3, 2024, updating corporate info. Nothing major, just housekeeping.
AI Summary
Replimune Group, Inc. filed an 8-K on June 3, 2024, reporting other events and financial statements. The filing details the company's principal executive offices located at 500 Unicorn Park Drive, Suite 303, Woburn, MA 01801, and its principal executive office telephone number is (781) 222-9600. The company is incorporated in Delaware and its fiscal year ends on March 31.
Why It Matters
This filing provides essential corporate information and updates for investors and stakeholders regarding Replimune Group, Inc.'s operational and financial reporting structure.
Risk Assessment
Risk Level: low — The filing is a routine corporate update and does not contain information that suggests immediate financial or operational risk.
Key Players & Entities
- Replimune Group, Inc. (company) — Registrant
- June 3, 2024 (date) — Date of earliest event reported
- 500 Unicorn Park Drive Suite 303 Woburn , MA 01801 (address) — Address of principal executive offices
- ( 781 ) 222-9600 (phone_number) — Registrant's telephone number
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves to report other events and financial statements for Replimune Group, Inc.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 3, 2024.
Where are Replimune Group, Inc.'s principal executive offices located?
Replimune Group, Inc.'s principal executive offices are located at 500 Unicorn Park Drive Suite 303 Woburn, MA 01801.
What is the telephone number for Replimune Group, Inc.'s principal executive offices?
The telephone number for Replimune Group, Inc.'s principal executive offices is (781) 222-9600.
In which state is Replimune Group, Inc. incorporated?
Replimune Group, Inc. is incorporated in Delaware.
Filing Stats: 434 words · 2 min read · ~1 pages · Grade level 11 · Accepted 2024-06-03 09:27:39
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share REPL The Nasdaq Stock Mar
Filing Documents
- tm2416257d1_8k.htm (8-K) — 25KB
- tm2416257d1_ex99-1.htm (EX-99.1) — 21KB
- 0001104659-24-067556.txt ( ) — 221KB
- repl-20240603.xsd (EX-101.SCH) — 3KB
- repl-20240603_lab.xml (EX-101.LAB) — 33KB
- repl-20240603_pre.xml (EX-101.PRE) — 22KB
- tm2416257d1_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On June 3, 2024, Replimune Group, Inc. (the "Company") issued a news release announcing data updates from certain of its RP1 and RP2 programs. A copy of the news release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein. The Company undertakes no obligation to update, supplement or amend the materials attached hereto.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 News Release dated June 3, 2024 104 Cover page interactive data file (formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REPLIMUNE GROUP, INC. Date: June 3, 2024 By: /s/ Sushil Patel Sushil Patel Chief Executive Officer